Grace P A, Pitt H A, Longmire W P
Br J Surg. 1986 Aug;73(8):647-50. doi: 10.1002/bjs.1800730824.
For many years, the classical Whipple procedure has been the standard operative treatment for resectable periampullary cancer. Recently, the pylorus preservation operation has also been applied to periampullary tumours. This newer procedure has potential advantages in terms of ease of performance and postoperative physiology, but has yet to be proved as an adequate cancer operation. We, therefore, undertook the present retrospective analysis to compare the outcome following the pylorus preservation operation (n = 13) with that of the classical Whipple resection (n = 13) in 26 patients with histologically proved adenocarcinoma of the head of the pancreas. The two groups of patients were comparable for age, sex, pre-operative laboratory data, and resected margins free from tumour. More patients undergoing the classical Whipple resection had Stage I disease (10 versus 4, P less than 0.05). However, this difference would not be significant if the two patients in the pylorus preservation group with carcinomas in situ were considered to have stage I disease. Mean tumour diameter in the pylorus preservation patient group (3.2 +/- 0.6 cm) was smaller (P less than 0.05) than in the classical Whipple group (4.1 +/- 1.0 cm) but more patients in the pylorus preservation group also had metastases to the regional lymph nodes (54 versus 23 per cent). Overall operative morbidity (31 per cent) and mortality (4 per cent) was acceptable and did not differ between the two groups. Five year actuarial survival for pylorus preservation (25 per cent) was comparable to that observed for the Whipple procedure in this and other series.
多年来,经典的惠普尔手术一直是可切除壶腹周围癌的标准手术治疗方法。最近,保留幽门的手术也已应用于壶腹周围肿瘤。这种新手术在操作简便性和术后生理功能方面具有潜在优势,但尚未被证明是一种足够有效的癌症手术。因此,我们进行了本次回顾性分析,以比较13例接受保留幽门手术的患者与13例接受经典惠普尔切除术的患者的治疗结果,这26例患者均经组织学证实为胰头腺癌。两组患者在年龄、性别、术前实验室数据以及切缘无肿瘤方面具有可比性。接受经典惠普尔切除术的患者中I期疾病的患者更多(10例对4例,P<0.05)。然而,如果将保留幽门组中2例原位癌患者视为I期疾病,则这种差异并不显著。保留幽门患者组的平均肿瘤直径(3.2±0.6cm)小于经典惠普尔组(4.1±1.0cm)(P<0.05),但保留幽门组中更多患者也有区域淋巴结转移(54%对23%)。总体手术并发症发生率(31%)和死亡率(4%)是可以接受的,两组之间没有差异。保留幽门手术的5年精算生存率(25%)与本系列及其他系列中惠普尔手术的观察结果相当。